Patients with neuromuscular disorder.

This article describes the preoperative preparation of patients with neuromuscular disorders. These entities are a relatively rare and diverse group of diseases that can affect various organ systems in addition to the central nervous system. The anesthetic implications for the various comorbidities are varied and can be profound. These patients should be optimized before surgery, with the involvement of a multidisciplinary team of specialists.

[1]  V. Lennon,et al.  Myasthenia gravis with autoimmune autonomic neuropathy , 2001, Autonomic Neuroscience.

[2]  R. Lewis,et al.  Disorders of Pulmonary Function, Sleep, and the Upper Airway in Charcot-Marie-Tooth Disease , 2007, Lung.

[3]  B. Herz.  Colonic anastomotic disruption in myasthenia gravis , 1987, Diseases of the colon and rectum.

[4]  R. J. Dumont,et al.  Acute Spinal Cord Injury, Part II: Contemporary Pharmacotherapy , 2001, Clinical neuropharmacology.

[5]  Roger Holder,et al.  Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. , 2010, The American journal of medicine.

[6]  L. Politano,et al.  The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. , 1990, International journal of cardiology.

[7]  M. Fehlings,et al.  An evidence-based review of decompressive surgery in acute spinal cord injury: rationale, indications, and timing based on experimental and clinical studies. , 1999, Journal of neurosurgery.

[8]  F. Maynard,et al.  Epidemiology of spasticity following traumatic spinal cord injury. , 1990, Archives of physical medicine and rehabilitation.

[9]  P. Bégin,et al.  Anesthetic and surgical complications in 219 cases of myotonic dystrophy , 1997, Neurology.

[10]  V. Juel.  Myasthenia gravis: management of myasthenic crisis and perioperative care. , 2004, Seminars in neurology.

[11]  N. Murray,et al.  The Lambert-Eaton myasthenic syndrome. A review of 50 cases. , 1988, Brain : a journal of neurology.

[12]  Davide Pareyson,et al.  Diagnosis, natural history, and management of Charcot–Marie–Tooth disease , 2009, The Lancet Neurology.

[13]  C. Lutz,et al.  Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice. , 2010, Human molecular genetics.

[14]  A. Hahn.  The challenge of respiratory dysfunction in Guillain-Barré syndrome. , 2001, Archives of neurology.

[15]  A. Schubert,et al.  Multiple sclerosis and anesthetic implications , 2002, Current opinion in anaesthesiology.

[16]  S. Iannaccone,et al.  Pulmonary Function in Spinal Muscular Atrophy , 1994, Journal of child neurology.

[17]  R. Miller,et al.  Bulbar amyotrophic lateral sclerosis: Patterns of progression and clinical management , 1989, Head & neck.

[18]  BARBARA J. Mudge,et al.  Perioperative hazards in myotonic dystrophy , 1980, Anaesthesia.

[19]  R. Hughes,et al.  Corticosteroids for treating Guillain-Barre syndrome.[update of Cochrane Database Syst Rev. 2000;(2):CD001446; PMID: 10796795]. [Review] [31 refs] , 2000 .

[20]  M. Mirski,et al.  Critical Care and Perioperative Management in Traumatic Spinal Cord Injury , 2003, Journal of neurosurgical anesthesiology.

[21]  L. Aldridge.  Anaesthetic problems in myotonic dystrophy. A case report and review of the Aberdeen experience comprising 48 general anaesthetics in a further 16 patients. , 1985, British journal of anaesthesia.

[22]  T. Bertorini.  Neuromuscular disorders : treatment and management , 2011 .

[23]  A. Emery,et al.  The muscular dystrophies , 2002, The Lancet.

[24]  R. Griggs,et al.  Cardiac conduction in myotonic dystrophy. , 1975, The American journal of medicine.

[25]  P. Brugada,et al.  Malignant Ventricular Arrhythmia in a Case of Adult Onset of Spinal Muscular Atrophy (Kugelberg–Welander Disease) , 2009, Journal of cardiovascular electrophysiology.

[26]  J. Slaets,et al.  Psychotropic drugs and the perioperative period: a proposal for a guideline in elective surgery. , 2006, Psychosomatics.

[27]  W. Engel,et al.  Cardiac findings in Charcot-Marie-Tooth disease. A prospective study of 68 patients. , 1979, Archives of internal medicine.

[28]  S. Goodman,et al.  Perioperative Management of Medications Used in the Treatment of Rheumatoid Arthritis , 2006, HSS Journal.

[29]  A. Jackson,et al.  Long-term medical complications after traumatic spinal cord injury: a regional model systems analysis. , 1999, Archives of physical medicine and rehabilitation.

[30]  Tomohito Saito,et al.  Preoperative steroid therapy stabilizes postoperative respiratory conditions in myasthenia gravis , 2008, General thoracic and cardiovascular surgery.

[31]  P. Hambly,et al.  Anaesthesia for chronic spinal cord lesions , 1998, Anaesthesia.

[32]  J. Newburger,et al.  Cardiovascular Health Supervision for Individuals Affected by Duchenne or Becker Muscular Dystrophy , 2005, Pediatrics.

[33]  K. Fish,et al.  Cardiovascular complications during anesthesia in chronic spinal cord injured patients. , 1981, Anesthesiology.

[34]  J. Tetzlaff,et al.  Arrhythmia and Charcot-Marie-Tooth disease during anesthesia , 2000, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[35]  A. Leet,et al.  Surgical Treatment of Scoliosis in a Spinal Muscular Atrophy Population , 1990, Spine.

[36]  J. Stevens,et al.  Practice parameter: Immunotherapy for Guillain–Barré syndrome , 2003, Neurology.

[37]  A. Jaretzki,et al.  "Maximal" thymectomy for myasthenia gravis. Surgical anatomy and operative technique. , 1988, The Journal of thoracic and cardiovascular surgery.

[38]  P. Lichtenfeld.  Autonomic dysfunction in the Guillain-Barré syndrome , 1971 .

[39]  Mitchell R Lunn,et al.  Spinal muscular atrophy , 2008, The Lancet.

[40]  B. Brown,et al.  Guanethibine Sulfate in the Prevention of Autonomic Hyperreflexia , 1979 .

[41]  W. Edwards,et al.  Pathology of the cardiac conduction system in myotonic dystrophy: a study of 12 cases. , 1988, Journal of the American College of Cardiology.

[42]  Namita Singh,et al.  Gabapentin for the Treatment of Pain in Guillain-Barré Syndrome: A Double-Blinded, Placebo-Controlled, Crossover Study , 2002, Anesthesia and analgesia.

[43]  J. Sancho,et al.  Efficacy of mechanical insufflation-exsufflation in medically stable patients with amyotrophic lateral sclerosis. , 2004, Chest.

[44]  T. Bertorini.  1 – Introduction: Evaluation of Patients with Neuromuscular Disorders , 2011 .

[45]  J. Grider,et al.  Perioperative management of patients with an intrathecal drug delivery system for chronic pain. , 2008, Anesthesia and analgesia.

[46]  J. Antognini.  Anaesthesia for charcot-marie-tooth disease: a review of 86 cases , 1992, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[47]  H. Mitsumoto,et al.  Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review) , 2009, Neurology.

[48]  C. Kao,et al.  Gastric Emptying in Spinal Cord Injury Patients , 1999, Digestive Diseases and Sciences.

[49]  O. Hein-Sørensen,et al.  Complications during anaesthesia in patients with Duchenne’s muscular dystrophy (a retrospective study) , 1989, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[50]  Abhishek Kumar,et al.  The Comparative Evaluation of Gabapentin and Carbamazepine for Pain Management in Guillain-Barré Syndrome Patients in the Intensive Care Unit , 2005, Anesthesia and analgesia.

[51]  P. Morris.  Duchenne muscular dystrophy: a challenge for the anaesthetist , 1997, Paediatric anaesthesia.

[52]  V. Nelson,et al.  Death after acute withdrawal of intrathecal baclofen: case report and literature review. , 1999, Archives of physical medicine and rehabilitation.

[53]  Eric Garshick,et al.  Respiratory dysfunction and management in spinal cord injury. , 2006, Respiratory care.

[54]  R. Rudick,et al.  Pulmonary function and dysfunction in multiple sclerosis. , 1988, Archives of neurology.

[55]  R. Mantegazza,et al.  Current and emerging therapies for the treatment of myasthenia gravis , 2011, Neuropsychiatric disease and treatment.

[56]  S. Colachis.  Autonomic hyperreflexia with spinal cord injury. , 1992, The Journal of the American Paraplegia Society.

[57]  G. Siciliano,et al.  Gastric emptying in myotonic dystrophic patients. , 2002, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[58]  Jhp Hui,et al.  Pulmonary function and scoliosis in children with spinal muscular atrophy types II and III , 2003, Journal of paediatrics and child health.

[59]  R. Deane,et al.  Anesthesia and the Control of Blood Pressure in Patients with Spinal Cord Injury , 1982, Anesthesia and analgesia.

[60]  R. Kinkel,et al.  Management of multiple sclerosis. , 1997, The New England journal of medicine.

[61]  Richard J Barohn,et al.  Supportive care for patients with Guillain-Barré syndrome. , 2005, Archives of neurology.

[62]  A. Blandino,et al.  Cardiovascular autonomic dysfunction in multiple sclerosis is likely related to brainstem lesions , 1993, Journal of the Neurological Sciences.

[63]  Jeffrey A. Cohen,et al.  Severe brachial plexopathy after an ultrasound-guided single-injection nerve block for total shoulder arthroplasty in a patient with multiple sclerosis. , 2008, Anesthesiology.

[64]  V. Majithia,et al.  Myasthenia gravis and systemic lupus erythematosus: truly associated or coincidental—two case reports and review of the literature , 2006, Clinical Rheumatology.

[65]  R. Hirsh,et al.  Prediction of the Need for Postoperative Mechanical Ventilation in Myasthenia Gravis , 1980, Anesthesiology.

[66]  J. Parrillo,et al.  Cardiac Disease in Myasthenia Gravis: A Literature Review , 2003, Journal of clinical neuromuscular disease.

[67]  E. Viggiano,et al.  Cardiac involvement in patients with Spinal Muscular Atrophies , 2011, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

[68]  Y. Toyama,et al.  Cardiac Involvement in the Kugelberg-Welander Syndrome , 1976 .

[69]  H. Hartung,et al.  Guillain-Barré syndrome. , 2012, The New England journal of medicine.

[70]  A. Hillel,et al.  Palliative surgery in patients with bulbar amyotrophic lateral sclerosis , 1989, Head & neck.

[71]  P. Andersen,et al.  Good practice in the management of amyotrophic lateral sclerosis: Clinical guidelines. An evidence‐based review with good practice points. EALSC Working Group , 2007, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[72]  K. Lyons,et al.  Metoclopramide-induced normalization of impaired gastric emptying in spinal cord injury. , 1987, The American journal of gastroenterology.

[73]  J. Bach.  Amyotrophic lateral sclerosis: prolongation of life by noninvasive respiratory AIDS. , 2002, Chest.

[74]  P. Flachenecker.  Epidemiology of neuroimmunological diseases , 2006, Journal of Neurology.

[75]  R. Schiffer,et al.  Treatment of pathologic laughing and weeping with amitriptyline , 1985 .

[76]  J. Davis,et al.  REMISSION OF MYASTHENIA GRAVIS FOLLOWING PLASMA-EXCHANGE , 1976, The Lancet.

[77]  Y. Sohara,et al.  Experience with programmed steroid treatment with thymectomy in nonthymomatous myasthenia gravis. , 2004, The Annals of thoracic surgery.

[78]  W. Buie,et al.  Perioperative stress dose steroids: do they make a difference? , 2001, Journal of the American College of Surgeons.

[79]  C. M. Wiles,et al.  Respiratory involvement in multiple sclerosis. , 1992, Brain : a journal of neurology.

[80]  D. B. Drachman,et al.  Myasthenia gravis. , 1994, The New England journal of medicine.

[81]  L. Wilkins.  Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology , 2010, Neurology.

[82]  E. Fonkalsrud,et al.  THYMECTOMY FOR MYASTHENIA GRAVIS. , 1963, Annals of surgery.

[83]  M. Rockoff,et al.  Anesthesia-related complications in children with Duchenne muscular dystrophy. , 1988, Anesthesiology.

[84]  R. J. Dumont,et al.  Acute Spinal Cord Injury, Part I: Pathophysiologic Mechanisms , 2001, Clinical neuropharmacology.

[85]  J. P. Gallagher.  Pathologic laughter and crying in ALS: a search for their origin , 1989, Acta neurologica Scandinavica.

[86]  G. Borasio,et al.  Amyotrophic lateral sclerosis , 2007, The Lancet.

[87]  N. Hirsch,et al.  Anaesthesia and myotonia. , 1994, British journal of anaesthesia.

[88]  S. Chevret,et al.  Early predictors of mechanical ventilation in Guillain-Barré syndrome , 2003, Critical care medicine.

[89]  M. Schroth,et al.  American College of Chest Physicians consensus statement on the respiratory and related management of patients with Duchenne muscular dystrophy undergoing anesthesia or sedation. , 2007, Chest.

[90]  T. Feasby,et al.  Pain in Guillain-Barre syndrome , 1997, Neurology.

[91]  E. Heyer,et al.  PROBLEMS OF ANESTHESIA IN PATIENTS WITH NEUROMUSCULAR DISEASE , 1997 .

[92]  S. Chevret,et al.  Clinical trial of plasma exchange and high‐dose intravenous immunoglobulin in myasthenia gravis , 1997 .

[93]  Robert G. Miller,et al.  Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). , 2007, The Cochrane database of systematic reviews.

[94]  Intrathecal Baclofen for Severe Spinal Spasticity , 1990 .

[95]  J. Gilroy,et al.  Cardiac and Pulmonary Complications in Duchenne's Progressive Muscular Dystrophy , 1963, Circulation.